A bivalent SARS-CoV-2 monoclonal antibody combination does not impact the immunogenicity of a vector-based COVID-19 vaccine in macaques
A human SARS-CoV-2 monoclonal antibody cocktail can be co-administered with a SARS-CoV-2 viral vector-based vaccine.